David A. Smythe

David A. Smythe serves as a procurement specialist responsible for managing complex acquisitions in support of scientific, technical, and pharmaceutical research initiatives. Though his formal title is not disclosed, his contracting patterns indicate a central role in executing procurements aligned with federal research and development priorities. He typically handles requirements for analytical instrumentation, laboratory services, pharmaceutical manufacturing, and specialized technical consulting, ensuring compliance with federal acquisition regulations and mission-driven outcomes. His work supports the acquisition lifecycle from market research through contract award and administration, with a strong emphasis on technical precision and regulatory adherence. Smythe’s contractor relationships are characterized by engagement with a diverse pool of vendors, including established manufacturers of analytical laboratory equipment, contract research organizations, and scientific consulting firms. While no single contractor dominates his portfolio, he consistently works with firms capable of delivering high-complexity, regulated products and services. His procurement approach favors technical capability over volume, often requiring vendors to demonstrate validated processes, quality control systems, and compliance with Good Manufacturing Practices or ISO standards. His contracting activity reflects a strong preference for open competition, with 89.7% of awards issued under non-set-aside authorities. Nevertheless, he maintains a deliberate and consistent commitment to small business participation, allocating 10.3% of his acquisitions to Total Small Business Set-Asides under FAR 19.5. This pattern signals a balanced approach—prioritizing broad market access while intentionally fostering opportunities for qualified small businesses without reliance on specialized socioeconomic programs like 8(a) or HUBZone. Smythe’s primary procurement focus centers on NAICS 325412 (Pharmaceutical Preparation Manufacturing) and 511210 (Software Publishers), each representing 13.9% of his activity, alongside significant engagement in 541690 (Technical Consulting) and 541380 (Testing Laboratories). These categories reflect deep expertise in procuring regulated pharmaceuticals, proprietary software solutions for scientific data, and certified analytical services. His domain knowledge spans laboratory automation, drug formulation, and precision instrumentation, positioning him as a specialist in science-driven federal procurement.